Duodenoscope-Associated Infections: Update on an Emerging Problem.
M Rubayat RahmanAbhilash PerisettiRoxana ComanPardeep BansalRajiv ChhabraHemant GoyalPublished in: Digestive diseases and sciences (2018)
The duodenoscope is among the most complex medical instruments that undergo disinfection between patients. Transmission of infection by contaminated scopes has remained a challenge since its inception. Notable risk factors for pathogen transmission include non-adherence to disinfection guidelines, encouragement of biofilm deposition due to complex design and surface defects and contaminated automated endoscope reprocessors. The most common infections following endoscopy are endogenous infections involving the patient's own gut flora. Exogenous infections, on the other hand, are associated with contaminated scopes and can theoretically be prevented by effective reprocessing. Pseudomonas aeruginosa is currently the most common organism isolated from contaminated endoscopes. Of note, reports of multidrug-resistant duodenoscopy-associated outbreaks have surfaced recently, many of which occurred despite adequate reprocessing. The FDA and CDC currently recommend comprehensive cleaning followed with at least high-level disinfection for reprocessing of flexible GI endoscopes. Reports of duodenoscope-related outbreaks despite compliance with established guidelines have prompted professional and government bodies to revisit existing guidelines and offer supplementary recommendations for duodenoscope processing. For the purposes of this review, we identified reports of duodenoscope-associated infections from 2000 till date. For each outbreak, we noted the organisms isolated, the number of cases reported, any possible explanations of contamination, and the measures undertaken to end each outbreak. We have also attempted to present an overview of recent developments in this rapidly evolving field.
Keyphrases
- drinking water
- pseudomonas aeruginosa
- heavy metals
- multidrug resistant
- clinical practice
- health risk
- end stage renal disease
- healthcare
- ejection fraction
- risk assessment
- chronic kidney disease
- newly diagnosed
- acinetobacter baumannii
- candida albicans
- drug resistant
- prognostic factors
- adverse drug
- type diabetes
- emergency department
- gram negative
- biofilm formation
- cell proliferation
- deep learning
- cell cycle
- metabolic syndrome
- patient reported outcomes
- single cell
- human health
- glycemic control
- insulin resistance
- small bowel